SBIR PHASE I- TOPIC 410 - CANCER CLINICAL TRIALS RECRUITMENT AND RETENTION TOOLS FOR PARTICIPANT ENGAGEMENT.

SBIR 第一阶段 - 主题 410 - 癌症临床试验招募和保留参与者参与的工具。

• 批准号: 10269299
• 负责人: HOWARD ISENSTEIN
• 金额: $ 40万
• 依托单位: CARE PROGRESS, LLC
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-16 至 2021-06-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10269299
• 关键词: Cancer Patient; Clinical Research; Clinical Trials; Computer software; Consensus; Data; Education; Feedback; Goals; Health; Institutional Review Boards; Interview; Laws; Letters; Needs Assessment; Oncologist; Oncology; Participant; Patient Recruitments; Patients; Phase; Privacy; Regulation; Research; Research Project Grants; Review Literature; Security; Site; Small Business Innovation Research Grant; Surveys; System; Technology; Testing; base; cancer clinical trial; prospective; prototype; recruit; tool; usability

This research project seeks to create targeted content and software, OncoEngage, to increase recruitment of oncology patients in clinical trials. The overall goal is to aid clinical research coordinators and others to engage prospective participants to join trials. The Phase I is focused on creating targeted content to engage and recruit participants into clinical trials and adapting customer relationship management software to enable research staff to efficiently and effectively perform engagement activities to recruit prospective participants.

该研究项目旨在创建有针对性的内容和软件OncoEngage，以增加临床试验中肿瘤患者的招募。总体目标是帮助临床研究协调员和其他人吸引潜在参与者加入试验。第一阶段的重点是创建有针对性的内容，以吸引和招募参与者参加临床试验，并调整客户关系管理软件，使研究人员能够高效地执行参与活动，以招募潜在的参与者。